Mumbai police ban photography, circulation of images of half-submerged Durga idols

US Market Outlook: Bourses hold gains

The benchmark indices have more room to rise

Tessolve raises $75 million from US-based Vector Line Capital

The funds will support Tessolve's growth, including strategic acquisitions that add to its existing capabilities, widen its service offerings, and strengthen its global footprint

Crude oil futures brace for volatility amid geopolitical uncertainties: Analysts

MCX crude oil futures for October delivery fell ₹35, or 0.4%, last week to settle at ₹8,881 per barrel

From The Mummy’s Imhotep to Ranabaali’s Hector: Who is Arnold Vosloo, the villain facing Vijay Deverakonda and Rashmika Mandanna?

Who is Arnold Vosloo acting as Theodore in Ranabaali? Hector South African actor Arnold Vosloo, best known as Imhotep in The Mummy, is now playing Sir Theodore Hector in Vijay Deverakonda and Rashmika Mandanna's period drama Ranabaali. The film portrays a story of colonial India when millions of people died.

Q2 earnings, inflation data, oil prices to guide stock markets this week: Analysts

Market investors to also watch foreign investor trading activity, rupee movement, US Treasury yields, and geopolitical developments

IPO rush continues: Jio Platforms, Zetwerk among dozen cos set to tap primary market in Oct

Proposed offerings span sectors such as technology, healthcare, renewable energy, defence and precision manufacturing

FPIs pull out ₹44,166 cr from equities so far in Oct; 2026 outflows cross ₹3 lakh cr

The latest outflows follow a net withdrawal of ₹35,861 crore in September

‘I might be arrested, but I’m not worried’: Dipke vows to hoist flag amid heavy security in Delhi

‘I might be arrested, but I’m not worried’: Dipke vows to hoist flag amid heavy security in Delhi

Fusion CX IPO Day 3: Check GMP, subscription status; Should you apply?

Fusion CX’s Rs 702 crore IPO entered its final bidding day, with 1.10 times subscription on Day 2 and an 8% grey market premium. Brokerages highlight growth potential, improving profitability, AI-driven demand and reasonable valuations, while proceeds will primarily reduce debt and fund technology upgrades.

Sahajanand Medical Technologies IPO Day 2: Check GMP, subscription status and key details

Sahajanand Medical Technologies IPO entered Day 2 on October 16, 2026, with a 12% GMP and 34% subscription on Day 1. The Rs 475.48-crore offer for sale is priced at Rs 327-344 per share. PAT surged 175% to Rs 69 crore in FY26 amid steady revenue growth.